Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026

Go back to Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026
AGENUS (NASDAQ: AGEN) Delayed: 6.19 +0.66 (11.93%)
Previous Close $5.53    52 Week High $7.49 
Open $5.53    52 Week Low $2.61 
Day High $6.23    P/E N/A 
Day Low $5.46    EPS $-1.10 
Volume 2,332,499